Replimune’s RP1+nivolumab melanoma BLA faces an FDA decision by Apr 10, 2026. The current cash runway extends to Q1'27. See ...

Dolby Laboratories (DLB) closed the last trading session at $63.65, gaining 3.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.

Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.

From Anthropic to Replit, these are the key vibe-coding players to follow. In a blog post published in early January, OpenAI CEO Sam Altman opined that in 2025, the first AI agents would enter the ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

The domain AI.com was just purchased for a record-breaking amount of money. It already had a commercial at the Super Bowl.

Former Manchester United midfielder Owen Hargreaves has explained the tactical change implemented by caretaker manager ...

We’re entering a new renaissance of software development. We should all be excited, despite the uncertainties that lie ahead.

In Minneapolis, videos of the Alex Pretti killing undermined the federal government’s account. But an A.I. video of Brad Pitt shows the dangers ahead.